EW – edwards lifesciences corporation (US:NYSE)

DELAYED
$ usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day EW SPY QQQ SPX
Date
Time
Symbol
Company Name
Action
%Chg
10/30/2025
04:13 pm
ew
edwards lifesciences corporation
BEAT
-1.2%
7/24/2025
04:15 pm
ew
edwards lifesciences corporation
BEAT
5.5%
4/23/2025
04:15 pm
ew
edwards lifesciences corporation
BEAT
6.6%
2/11/2025
04:15 pm
ew
edwards lifesciences corporation
BEAT
6.6%
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions?
The answers are right here.
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Top News Gainers
3/23 Form 4 Edwards Lifesciences For: Mar 23 Filed by: Szyman Catherine M. 17.6%
7/23 Q2/2019 6/30/2019 EPS 1.380 ZacksConsensus 1.320 ActVsEst 0.060 - Beat 9.8%
4/1 Form 4 Edwards Lifesciences For: Apr 01 Filed by: Lemercier Jean-Luc M 6.9%
3/9 Form 4 Edwards Lifesciences For: Mar 06 Filed by: BOBO DONALD E JR 6.2%
4/16 Form 4 Edwards Lifesciences For: Apr 16 Filed by: Szyman Catherine M. 5.0%
4/13 Form DEFA14A Edwards Lifesciences 4.9%
3/25 Form DEFA14A Edwards Lifesciences 4.5%
4/9 Edwards Lifesciences Corp (NYSE: EW) had its price target lowered by analysts at Raymond James from $263.00 to $230.00. They now have an "outperform" rating on the stock. 4.1%
10/25 Form 10-Q Edwards Lifesciences For: Sep 30 4.0%
2/3 Form 4 Edwards Lifesciences For: Feb 03 Filed by: Lemercier Jean-Luc M 3.7%
Top News Decliners
1/30 Form 8-K Edwards Lifesciences For: Jan 30 -10.6%
4/24 Edwards Lifesciences Corp (NYSE: EW) had its "buy" rating re-affirmed by analysts at Citigroup Inc. They now have a $255.00 price target on the stock, up previously from $240.00. -5.7%
3/20 Form 4 Edwards Lifesciences For: Mar 19 Filed by: MUSSALLEM MICHAEL A -5.1%
4/27 Edwards Lifesciences Corp (NYSE: EW) had its "underweight" rating re-affirmed by analysts at Barclays PLC. They now have a $155.00 price target on the stock, down previously from $165.00. -5.0%
10/24 Edwards Lifesciences Corp (NYSE: EW) had its "overweight" rating re-affirmed by analysts at Piper Jaffray Companies. They now have a $255.00 price target on the stock, up previously from $240.00. -4.0%
4/28 Edwards Lifesciences Corp (NYSE: EW) was downgraded by analysts at Wells Fargo & Co from an "overweight" rating to an "equal weight" rating. -3.5%
4/30 Form 4 Edwards Lifesciences For: Apr 30 Filed by: Szyman Catherine M. -3.1%
3/30 Form 4 Edwards Lifesciences For: Mar 30 Filed by: WANG HUIMIN -3.0%
9/6 Form 4 Edwards Lifesciences For: Sep 06 Filed by: BOBO DONALD E JR -2.7%
3/2 Form 4 Edwards Lifesciences For: Mar 02 Filed by: Wood Larry L -2.5%

Don’t Miss Out On The Next BIG Stock Move

Thanks for submitting the form.
EW – edwards lifesciences corporation (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
EW
SPY
QQQ
SPX
EW – edwards lifesciences corporation (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
EW SPY QQQ SPX
Stock Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Stock Stats
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
News
12/11
07:20 am
ew
Low
Edwards Lifesciences (NYSE:EW) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
12/8
07:22 am
ew
Low
Edwards Lifesciences (NYSE:EW) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
12/5
07:07 pm
ew
Low
Will Edwards Lifesciences' (EW) Upgraded 2025–2026 Outlook Reshape Its Long-Term Growth Narrative? [Yahoo! Finance]
12/5
11:44 am
ew
Low
Edwards Lifesciences' Long-term Business Outlook Appears Achievable, RBC Says [Yahoo! Finance]
12/5
10:58 am
ew
Low
Edwards Lifesciences (NYSE:EW) was given a new $92.00 price target on by analysts at UBS Group AG.
12/5
09:47 am
ew
Low
Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Royal Bank Of Canada from $95.00 to $100.00. They now have an "outperform" rating on the stock.
12/5
08:43 am
ew
Low
Edwards Lifesciences (NYSE:EW) was given a new $100.00 price target on by analysts at Stifel Nicolaus.
12/5
08:43 am
ew
Low
Edwards Lifesciences (NYSE:EW) was given a new $92.00 price target on by analysts at Truist Financial Corporation.
12/5
08:43 am
ew
Low
Edwards Lifesciences (NYSE:EW) was given a new $89.00 price target on by analysts at Canaccord Genuity Group Inc..
10/30/2025
04:13 pm
ew
-1.2%
BEAT
7/24/2025
04:15 pm
ew
5.5%
BEAT
4/23/2025
04:15 pm
ew
6.6%
BEAT
2/11/2025
04:15 pm
ew
6.6%
BEAT
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions? The answers are right here.
12/11
03:59 pm
Maintains
Buy
Buy
Citigroup
Low
0.0%
12/11
03:59 pm
Maintains
Buy
Buy
Citigroup
Low
0.0%
12/11
07:20 am
Reiterates
Buy
Buy
Citigroup Inc.
Low
0.3%
12/8
10:37 am
Maintains
Overweight
Overweight
Barclays
Low
-1.3%
12/8
10:37 am
Maintains
Overweight
Overweight
Barclays
Low
-1.3%
12/8
07:22 am
Reiterates
Overweight
Overweight
Barclays PLC
Low
-2.0%
12/5
02:11 pm
Maintains
Hold
Hold
Canaccord Genuity
Low
-0.9%
12/5
12:35 pm
Maintains
Buy
Buy
Stifel
Low
-0.7%
12/5
11:24 am
Maintains
Neutral
Neutral
UBS
Low
-1.8%
12/12
05:58 pm
ew
Low
Form 4 Edwards Lifesciences For: Dec 12 Filed by: Lippis Daniel J.
12/12
05:58 pm
ew
Low
Form 4 Edwards Lifesciences For: Dec 12 Filed by: STONE HEISZ LESLIE
12/12
05:58 pm
ew
Low
Form 4 Edwards Lifesciences For: Dec 12 Filed by: BOBO DONALD E JR
12/12
04:22 pm
ew
Low
Form 144 Edwards Lifesciences Filed by: BOBO DONALD E JR
12/12
04:05 pm
ew
Low
Form 144 Edwards Lifesciences Filed by: STONE HEISZ LESLIE
12/12
04:04 pm
ew
Low
Form 144 Edwards Lifesciences Filed by: BOBO DONALD E JR
12/11
05:59 pm
ew
Low
Form 4 Edwards Lifesciences For: Dec 11 Filed by: Chopra Daveen
12/11
04:01 pm
ew
Low
Form 144 Edwards Lifesciences Filed by: Chopra Daveen
12/10
06:59 pm
ew
Low
Form 4 Edwards Lifesciences For: Dec 08 Filed by: Zovighian Bernard J
Show more
Top News Gainers
3/23 Form 4 Edwards Lifesciences For: Mar 23 Filed by: Szyman Catherine M. 17.6%
7/23 Q2/2019 6/30/2019 EPS 1.380 ZacksConsensus 1.320 ActVsEst 0.060 - Beat 9.8%
4/1 Form 4 Edwards Lifesciences For: Apr 01 Filed by: Lemercier Jean-Luc M 6.9%
3/9 Form 4 Edwards Lifesciences For: Mar 06 Filed by: BOBO DONALD E JR 6.2%
4/16 Form 4 Edwards Lifesciences For: Apr 16 Filed by: Szyman Catherine M. 5.0%
4/13 Form DEFA14A Edwards Lifesciences 4.9%
3/25 Form DEFA14A Edwards Lifesciences 4.5%
4/9 Edwards Lifesciences Corp (NYSE: EW) had its price target lowered by analysts at Raymond James from $263.00 to $230.00. They now have an "outperform" rating on the stock. 4.1%
10/25 Form 10-Q Edwards Lifesciences For: Sep 30 4.0%
2/3 Form 4 Edwards Lifesciences For: Feb 03 Filed by: Lemercier Jean-Luc M 3.7%
Top News Decliners
1/30 Form 8-K Edwards Lifesciences For: Jan 30 -10.6%
4/24 Edwards Lifesciences Corp (NYSE: EW) had its "buy" rating re-affirmed by analysts at Citigroup Inc. They now have a $255.00 price target on the stock, up previously from $240.00. -5.7%
3/20 Form 4 Edwards Lifesciences For: Mar 19 Filed by: MUSSALLEM MICHAEL A -5.1%
4/27 Edwards Lifesciences Corp (NYSE: EW) had its "underweight" rating re-affirmed by analysts at Barclays PLC. They now have a $155.00 price target on the stock, down previously from $165.00. -5.0%
10/24 Edwards Lifesciences Corp (NYSE: EW) had its "overweight" rating re-affirmed by analysts at Piper Jaffray Companies. They now have a $255.00 price target on the stock, up previously from $240.00. -4.0%
4/28 Edwards Lifesciences Corp (NYSE: EW) was downgraded by analysts at Wells Fargo & Co from an "overweight" rating to an "equal weight" rating. -3.5%
4/30 Form 4 Edwards Lifesciences For: Apr 30 Filed by: Szyman Catherine M. -3.1%
3/30 Form 4 Edwards Lifesciences For: Mar 30 Filed by: WANG HUIMIN -3.0%
9/6 Form 4 Edwards Lifesciences For: Sep 06 Filed by: BOBO DONALD E JR -2.7%
3/2 Form 4 Edwards Lifesciences For: Mar 02 Filed by: Wood Larry L -2.5%